8-K: SS Innovations Appoints Milan Rao as Global COO & CFO

SS Innovations International, Inc. announced the appointment of Milan Rao as Global Chief Operating Officer and Chief Financial Officer, following the resignation of Naveen Kumar Amar.

Summary

• Naveen Kumar Amar resigned as Chief Financial Officer of SS Innovations International, Inc. on January 2, 2026, citing personal reasons.
• On January 6, 2026, the company's board of directors appointed Milan Rao to the newly created position of Global Chief Operating Officer and as the new Chief Financial Officer, effective January 16, 2026.
• Mr. Rao, 54, brings over three decades of executive leadership experience in technology-enabled transformation, operational efficiency, and growth across global companies, including the healthcare sector.
• His prior roles include COO and CRO of Markets & Markets, President and Global Business Head of Smart Energy Water, President at Wipro Limited, and President & CEO for India & Emerging Markets at GE Healthcare.
• Mr. Rao will be based in Princeton, New Jersey, and will receive a monthly base compensation of $41,667, paid to his consulting firm, Strat Plus Consulting, LLC.
• He will also receive a stock grant of 120,000 shares of common stock under the company's 2016 Incentive Stock Plan, vesting in equal monthly installments of 10,000 shares.
• The Services Agreement includes customary confidentiality, assignment of proprietary rights, non-competition, and non-solicitation provisions for a period of twelve months post-termination.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to the appointment of a very experienced and highly qualified executive to a critical dual role, including a newly created strategic position. This signals a strong commitment to global expansion and operational excellence, which are key drivers for future growth.

Positives

• The appointment of Milan Rao, a highly experienced executive with over three decades of leadership in technology, operations, and finance, including significant healthcare sector experience, is a strong strategic move.
• The creation of the Global Chief Operating Officer role signifies the company's commitment to scaling global operations and enhancing operational efficiency.
• Mr. Rao's background in driving technology-enabled transformation and managing large-scale global businesses aligns with SS Innovations' stated goal of expanding the global footprint of its SSi Mantra surgical robotic system.
• Management comments highlight Mr. Rao's ability to build high-performance teams and grow multinational businesses, which is crucial for the company's strategic direction and long-term value creation.

Negatives

• The resignation of the former Chief Financial Officer, Naveen Kumar Amar, for 'personal reasons' could introduce a period of transition, although a replacement has been promptly named.

Risks

• Forward-looking statements in the press release are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied.

Future Outlook

The company aims to expand the global footprint of its SSi Mantra surgical robotic system, define its growth strategy, enhance operational readiness, and deliver long-term value creation by democratizing robotic surgery for a broader global population. Milan Rao is expected to play an integral role in achieving these strategic objectives.

Management Comments

• "Milan brings to SS Innovations a commendable track record of building high-performance teams and growing multinational businesses through his hands-on leadership approach. His appointment reflects our commitment to attracting top talent to our executive team as we continue to expand the global footprint of our advanced, cost-effective SSi Mantra surgical robotic system. Milan will play an integral role in defining our growth strategy and delivering on our promise of democratizing robotic surgery for a broader segment of patients in need." Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations.
• "I am pleased to begin working with Dr. Srivastava and the SS Innovations leadership team during this transition. SS Innovations has built a compelling and differentiated robotics platform and I look forward to contributing to the Company’s strategic direction, operational readiness and long-term value creation as the organization continues to evolve and scale." Milan Rao, Global Chief Operating Officer and Chief Financial Officer.

Industry Context

This announcement positions SS Innovations to capitalize on the growing demand for robotic surgery by focusing on affordability and accessibility. The appointment of a seasoned executive with a background in healthcare technology and global scaling suggests a strategic push to expand market share and operational capabilities in the competitive surgical robotics industry, aligning with broader trends of technological innovation and global healthcare access.

Comparison to Industry Standards

• NA The filing focuses on executive appointments and does not provide specific financial or operational metrics for direct comparison to industry benchmarks or competitors like Intuitive Surgical (da Vinci system) or Medtronic (Hugo RAS system).
• The company's stated vision to make robotic surgery 'affordable and accessible to a larger segment of the global population' implies a differentiation strategy compared to higher-cost established systems, but specific comparative data is not provided in this filing.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The appointment of a highly experienced executive is likely to be viewed positively, potentially enhancing confidence in the company's strategic direction and future growth prospects, which could positively impact share price.
• Employees: New leadership in a key operational and financial role may bring new strategies and efficiencies, potentially impacting organizational structure and work processes.
• Customers: The focus on global expansion and democratizing robotic surgery through cost-effective solutions suggests an intent to reach a broader customer base and improve access to advanced surgical technologies.
• Creditors/Suppliers: Stronger executive leadership in finance and operations could lead to more robust financial management and potentially more stable business relationships.

Next Steps

• Milan Rao will work closely with the Chairman and executive leadership team during a planned transition period.
• Mr. Rao will be responsible for signing the company's Annual Report on Form 10-K for the year ended December 31, 2025, and any amendments thereto, as well as any amendment to the DRS Form S-1 Registration Statement.
• The company plans to continue expanding the global presence of its SSi Mantra surgical robotic system.
• The company will focus on defining its growth strategy, enhancing operational readiness, and delivering long-term value creation.

Key Dates

Recommendation

The appointment of Milan Rao as Global COO and CFO is a significant positive development, bringing extensive experience and strategic leadership to SS Innovations. This move is expected to bolster the company's efforts in global expansion and operational efficiency, which are crucial for long-term value creation in the competitive surgical robotics market. While the news is fundamentally positive and strengthens the management team, this 8-K does not contain immediate financial performance data to warrant an aggressive 'buy' recommendation. Investors should 'hold' and monitor the execution of the company's strategic initiatives under the new leadership, looking for subsequent financial reports that reflect the impact of these changes.

Keywords

Surgical Robotics, Medical Devices, Chief Financial Officer, Chief Operating Officer, Executive Appointment, Corporate Governance, SSi Mantra, Healthcare Technology, Global Expansion, SEC Filing